VITROS 6802454Recalls & reported problems
Ortho Clinical Diagnostics · VITROS Immunodiagnostic Products Anti-HCV Reagent Pack · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 10758750002801), received between Dec 19, 2025 and Dec 19, 2025 — classified as 1 malfunction.
The most frequently reported specific device problem is “False Negative Result” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Reports received per month
Most reported problems
Device problems
- False Negative Result1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionDec 19, 2025False Negative Result; False Negative Result
A CUSTOMER CONTACTED THE ORTHO CLINICAL DIAGNOSTICS (ORTHO) TECHNICAL SOLUTION CENTER (TSC) TO REPORT A DISCORDANT, NON-REACTIVE (NEGATIVE) VITROS ANTI-HCV (AHCV) RESULT WAS OBTAINED FROM A NON-VITROS RANDOX INTERNATIONAL QUALITY ASSESSMENT SCHEME (RIQAS) PROFICIENCY FLUID USING VITROS IMMUNODIAGNOSTIC PRODUCTS AHCV REAGENT ON A VITROS XT 7600 INTEGRATED SYSTEM. THE RESULT WAS CONSIDERED DISCORDANT WHEN COMPARED TO THE REPEAT REACTIVE RESULTS FROM THE SAME SAMPLE ACROSS TWO ANALYZERS. RIQAS PROFICIENCY SAMPLE RESULT OF 0.66 S/C (NEGATIVE) VERSUS THE EXPECTED RESULT OF 1.18 S/C (REACTIVE) BIASED RESULTS OF THE MAGNITUDE AND DIRECTION OBSERVED MAY LEAD TO INAPPROPRIATE PHYSICIAN ACTION IF THEY WERE TO OCCUR UNDETECTED ON PATIENT SAMPLES. THE DISCORDANT, NON-REACTIVE VITROS AHCV RESULT WAS OBSERVED USING A NON-PATIENT FLUID AND WAS NOT REPORTED FROM THE LABORATORY. THERE HAS BEEN NO ALLEGATION OF PATIENT HARM AS A RESULT OF THIS EVENT. THIS REPORT CORRESPONDS TO ORTHO CLINICAL DIAGNOSTICS INC (ORTHO) COMPLAINT NUMBER: (B)(4).
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 23848895 ↗
Other ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS devices
- ADVIA Centaur® HCV 10309061Siemens Healthcare Diagnostics Inc. · Assay,Enzyme Linked Immunosorbent,Hepatitis C Virus108 reports
- ARCHITECT 1L79-25Abbott GmbH · ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS1 recall7 reports
- ARCHITECT 1L79-35Abbott GmbH · ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS1 recall3 reports
- Alinity 08P0521Abbott GmbH · Assay, enzyme linked immunosorbent, hepatitis c virus1 recall2 reports
- Elecsys Anti-HCV II 08837058190Roche Diagnostics GmbH · Assay, enzyme linked immunosorbent, hepatitis c virus44 reports
- Elecsys Anti-HCV II 08836981190Roche Diagnostics GmbH · Assay, enzyme linked immunosorbent, hepatitis c virus31 reports
- Elecsys Anti-HCV II 07026889190Roche Diagnostics GmbH · ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS26 reports
- Atellica™ IM aHCV 10995456Siemens Healthcare Diagnostics Inc. · ASSAY,ENZYME LINKED IMMUNOSORBENT,HEPATITIS C VIRUS22 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page